Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ascend Medical vs Lean Rx

Ascend Medical
Graded #426

Lower grade

vs+4.700000000000003
Lean Rx
Graded #319

Higher grade

The verdict

Lean Rx takes it — 60.6/100 to 55.9/100.

Lean Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lean Rx is a Sacramento-based telehealth technology platform offering compounded GLP-1 weight loss medications.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAscend Medical +5
45
40
Dose & formulationLean Rx +35
40
75
Clinical oversightAscend Medical +4
85
81
Labs & monitoringAscend Medical +10
62
52
FulfillmentLean Rx +1
59
60
Contract termsLean Rx +14
41
55
Ascend Medical · left barLean Rx · right bar

The numbers

MetricAscend MedicalLean Rx
WeighScore55.9/10060.6/100
GradeCC
Scorecard rank#426#319
SemaglutideNot disclosed$266/mo (starting dose, compounded)
TirzepatideNot disclosed$399/mo (starting dose, compounded)
Coverage2 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Ascend Medical

Graded #426 · C

Strengths

  • Whole-person virtual primary care that includes a medical weight loss program
  • Staffed by licensed MDs, DOs, NPs and PAs
  • Integrates weight loss with primary, mental health and diabetes care
  • Clear state availability (Georgia and Texas)

Where it loses points

  • Available only in Georgia and Texas
  • Specific GLP-1 medications and branded-vs-compounded status not published
  • No pricing disclosed on public pages
  • Weight loss is one service among many, not a dedicated GLP-1 specialist
Lean Rx

Graded #319 · C

Strengths

  • Both semaglutide and tirzepatide offered
  • Three formulations: injectable, sublingual, and tablet
  • Upfront pricing with no hidden fees advertised
  • Semaglutide starts at a low $266/month
  • Telehealth call with a licensed provider before prescribing

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • Platform is technology only, not a healthcare provider itself
  • Provider credentials not detailed on site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard